未知股票 ACOR 深 沪
已收盘
--
0.000
NaN.00%
华盛通- 最 高--
- 今 开--
- 成交量 --
- 最 低 --
- 昨 收 --
- 总市值 0
- 52周最高 --
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 --
- 委 比 0.00%
- 总股本 124.21万
- 历史最高 --
- 量 比 0
- 振 幅 NaN.00%
- 历史最低 --
- 每 手 1
- 风险率 3.08%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BRIEF-Overall Survival Primary Endpoint Met In Corcept’S Pivotal Phase 3 ROSELLA Trial Of Relacorilant In Patients With Platinum-Resistant Ovarian Cancer
BRIEF-Overall Survival Primary Endpoint Met In Corcept’S Pivotal Phase 3 ROSELLA Trial Of Relacorilant In Patients With Platinum-Resistant Ovarian Cancer Jan 22 (Reuters) - Corcept Therapeutics Inc CORT.O : OVERALL SURVIVAL PRIMARY ENDPOINT MET IN CORCEPT’S PIVOTAL PHASE 3 ROSELLA TRIAL OF RELACORIL
01-22 21:19
Birla Corporation Receives Voluntary ESG Score of 69.3 from SES ESG Research
An update from Birla Corporation Limited ( ($IN:BIRLACORPN) ) is now available....
01-01 14:13
BRIEF-Strategic Resources Announces Collaboration Agreement With Tacora Resources
Strategic Resources Inc SR.V: STRATEGIC RESOURCES ANNOUNCES COLLABORATION AGREEMENT WITH TACORA RESOURCES STRATEGIC RESOURCES INC - MAY PURCHASE UP TO 25% OF TACORA'S FUTURE CAPACITY Source text: ID:n...
2025-01-30 07:28
BRIEF-Strategic Resources Announces Collaboration Agreement With Tacora Resources
Strategic Resources Inc SR.V: STRATEGIC RESOURCES ANNOUNCES COLLABORATION AGREEMENT WITH TACORA RESOURCES STRATEGIC RESOURCES INC - MAY PURCHASE UP TO 25% OF TACORA'S FUTURE CAPACITY Source text: ID:n...
2025-01-30 07:28
BRIEF-Bridgebio Pharma Says Got $500 Mln Upon Acoramidis U.S. Food And Drug Administration Approval
Jan 13 (Reuters) - BridgeBio Pharma Inc BBIO.O: BRIDGEBIO PHARMA INC - RECEIVED $500 MILLION UPON ACORAMIDIS U.S. FOOD AND DRUG ADMINISTRATION APPROVAL Source text: [ID:n0001140361-25-000943] Further ...
2025-01-14 07:35
祁连国际盘中异动 大幅下挫8.34%
北京时间2024年04月10日22时16分，祁连国际（QLI.us）股票出现异动，股价大幅下挫8.34%。截至发稿，该股报0.655美元/股，成交量289股，换...
2024-04-10 22:16
坎伯兰药业盘中异动 早盘急速下跌5.32%报1.60美元
北京时间2024年04月10日21时35分，坎伯兰药业（CPIX.us）股票出现异动，股价急速下跌5.32%。截至发稿，该股报1.60美元/股，成交量6519股...
2024-04-10 21:35
阿尔凯默斯盘中异动 快速上涨6.09%报27.51美元
北京时间2024年04月09日21时31分，阿尔凯默斯（ALKS.us）股票出现波动，股价急速拉升6.09%。截至发稿，该股报27.51美元/股，成交量17....
2024-04-09 21:31
Nuwellis Filed U.S. Patent Application #20240108533: VENOUS BLOOD FLOW STIMULATOR FOR EXTRACORPOREAL THERAPY
https://ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20240108533
2024-04-05 03:53
